
The darkness hormone your brain makes — sold as a pill, dosed as a signal?
Melatonin is the hormone your pineal gland secretes when darkness falls — the chemical signal that tells every cell in your body that it is night. Its supplement version is the most-used sleep aid in America, and the most misunderstood: melatonin is not a sleeping pill — it is a timing signal. It shifts the circadian clock; it does not force unconsciousness the way a pharmaceutical hypnotic does. This distinction organizes everything on this page: why the dose is paradoxical (0.3 mg — a fraction of the shelf norm — matches the body's natural nighttime rise), why the timing is the pharmacology (taken at the wrong hour, it shifts you the wrong way), and why jet lag — not insomnia — is its most established use. The hormone is real, the signal is powerful, and the shelf's mega-doses are mostly a misunderstanding of what the molecule does.
A hormone synthesized in the pineal gland from serotonin, in a rhythm driven entirely by light: bright light suppresses it, darkness releases it. Peak nighttime blood levels (~100–200 pg/mL) are 3–10× the daytime baseline. The signal tells the body's periphery what time it is — a chemical dusk that begins roughly 2 hours before natural sleep onset (the process the supplement approximates).
The headline mechanism: melatonin advances or delays the body clock depending on when it's taken — the chronobiotic effect that makes it a jet-lag tool, not a knockout drop.
The 'opening of the sleep gate': rising melatonin marks the body's natural transition to sleep propensity — the supplement's signal, honestly sized (meta-analyses: ~7–12 minutes faster sleep onset, modest).
The field's most counterintuitive finding: 0.3 mg (physiologic) performs as well or better than 3–10 mg (pharmacologic) for sleep onset — higher doses add grogginess, not sleep. Less is more, and the shelf mostly sells more.
The most established use: timed melatonin at the destination shifts the clock faster than light alone — the Cochrane-endorsed protocol, the one use where the evidence is unambiguous.
The GI tract holds ~400× more melatonin than the brain — and melatonin receptors participate in lower-esophageal-sphincter tone (our acid-reflux page's small-trial story). The molecule is not only a brain hormone.
In laboratory contexts, melatonin is a potent antioxidant — a research literature that has not translated into clinical recommendations and belongs to the promise-not-product tier.
The mechanism explains the dosing discipline. Melatonin does not activate a sleep switch — it tells the circadian system that night has arrived. The MT1 and MT2 receptors in the suprachiasmatic nucleus read the signal and adjust the clock's phase. This is why timing matters more than dose: the same 1 mg taken at 6 PM, 8 PM, or midnight produces different clock shifts — and taken in the morning, it can push the clock the wrong direction entirely. The chronobiotic framing: melatonin is the body's 'darkness began' message, and the supplement is a synthetic version of that message — effective when the message's timing matches the intended shift.
0.3–1 mg — the physiologic signal
3 mg — the trial standard
The titration format
The dose paradox's victim
The MIT research program (Wurtman and colleagues) found ~0.3 mg reproduced the body's natural nighttime rise; 1 mg produced blood levels at the high end of physiologic. The dose that best matched the signal performed as well as higher doses for sleep onset — with less morning grogginess. The dose our top pick delivers.
10–30× the physiologic signal: blood levels far above anything the pineal produces. The higher doses do not sleep you faster — they add hangover grogginess, vivid dreams, and a longer plasma half-life. The shelf's arms race to 'max strength' is a category-wide misunderstanding of what the molecule does.
Melatonin occupies a regulatory gray zone that matters for the consumer: in the United States, it is sold as a dietary supplement — but it is chemically a hormone, not a nutrient. The body makes it (from serotonin, in the pineal), it acts on hormone receptors at picogram-level concentrations, and its production declines with age. In the EU, the regulatory picture is more honest about the chemistry: melatonin is available as a prescription medication at low doses, and only recently as a very-low-dose supplement. The practical implication for the American consumer: the product on the shelf is a hormone, sold without prescription, at doses often 10–30× physiologic — the restraint that a hormone deserves, applied by the consumer.
The pineal gland's story is the hormone's story: Descartes called it 'the seat of the soul' — the mind's physical interface. The 20th century found a humbler truth: a light-controlled clock-hand, secreting a timing molecule that the body reads as 'night has begun.' The supplement era added the third chapter: the signal, synthesized, dosed, and timed by the consumer — with the understanding of what the signal does (and what it doesn't) as the difference between a useful chronobiotic and a misunderstanding in a capsule.
The honest negative space — the melatonin aisle's persistent inflations: